• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. FRED; FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. FRED; FLOW DIVERTER Back to Search Results
Model Number UNKNOWN
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Activation Failure (3270)
Patient Problems Transient Ischemic Attack (2109); Stenosis (2263); Ischemia Stroke (4418)
Event Type  Injury  
Manufacturer Narrative
A search for non-conformances associated with the devices' part/lot number combination could not be performed as the lot and part numbers are unknown.The device was implanted in the patient and not returned to the manufacturer for evaluation.Procedural images were not provided; therefore the reported event could not be confirmed.The instructions for use (ifu) identifies in-stent thrombosis and stenosis of the stented segment as potential complications associated with use of the device.
 
Event Description
As reported through the article titled, "efficacy of the flow re direction endoluminal device for cerebral aneurysms and causes of failed deployment" during a single-center retrospective study the angiographic and clinical data of consecutive patients treated with the fred for cerebral unruptured aneurysms from june 2020 to may 2021 the following cases were reported: ischemic infarction occurred in one patient with transient paralysis of the arm during the perioperative period.No permanent morbidity or mortality was observed.The post-procedural pru with the administration of psg was significantly decreased compared to pre-treatment pru with the administration of cpg (146 (108.8-178.3) vs 207 (153.0-225.5), p<0.01).Angiographic follow-up was performed at 3 and 6 months after the procedure, and occlusion rate and in-stent stenosis were assessed.The occlusion rate was evaluated using the o'kelly-marotta (okm) grading scale [7].Okm grading scales c and d were defined as adequate occlusion.Patients with technical failure to deploy the fred were excluded from angiographic follow-up but were included in the clinical follow-up.In-stent stenosis of greater than 50% was recorded in one patient; inadequate occlusion rate (grade a) was found in two patients at the 3 months follow-up; inadequate occlusion rate (grade b) was found in four patients at the 3 month follow-up; inadequate occlusion rate (grade b) was found in one patient at the 6 month follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FRED
Type of Device
FLOW DIVERTER
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise drive
aliso viejo, CA 92656
7142478000
MDR Report Key13014381
MDR Text Key285240594
Report Number2032493-2021-00499
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P180027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-